Clinical TrialID 2210
Beta-cryptoxanthin Supplement: Absorption and Function
NCT05046457
Beta-cryptoxanthin Supplementation
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 2210
- Evidence Id
- 2210
- Core Evidence Id
- 2210
- Source Clinical Trial Id
- 2184
- Herb2 Clinical Trial Id
- HBCT002184
- Nct Id
- NCT05046457
- Title
- Beta-cryptoxanthin Supplement: Absorption and Function
- Status
- Completed
- Phase
- Study Result
- No
- Study Condition
- Beta-cryptoxanthin Supplementation
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
- Intervention
- DIETARY_SUPPLEMENT: Beta-cryptoxanthin (BCX)
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Triple
- Intervention Purpose
- Basic_Science
- Gender
- Female
- Age
- Adult
- Enrollment
- 90
- Outcome Measure
- Change in plasma concentration of BCX over 8 weeks, Fasting plasma carotenoids concentrations, Baseline, Week 2, Week 4, Week 8
- Sponsor Collaborator
- Institute for Human Development and Potential (IHDP), Singapore|DSM Nutritional Products, Inc.
- Funded By
- OTHER
- Location
- Singapore Institute for Clinical Sciences, Singapore, Singapore
- Other Id
- 2021/00455
- Start Date
- 2021-09-07
- Primary Completion Date
- 2022-03-31
- Completion Date
- 2022-03-31
- First Posted
- 2021-09-16
- Results First Posted
- Last Update Posted
- 2022-04-13
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT05046457
- Title Cn
- Title En
- Beta-cryptoxanthin Supplement: Absorption and Function
- Bilingual Status
- semi_complete